This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo
United Kingdom - English

United Kingdom - English

United Kingdom | English

These country specific websites are specifically intended for healthcare professionals in listed countries only.

Europe

Deutschland - DeutschDeutschland - Deutsch España - EspañolEspaña - Español Italia - ItalianoItalia - Italiano United Kingdom - EnglishUnited Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

Alcohol-Related Brain Damage (ARBD)

Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion is indicated in adults and children for rapid therapy of severe depletion or malabsorption of the water soluble vitamins B and C:1

Adverse Events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com

ALCOHOL-RELATED BRAIN DAMAGE

Provided by
KKI NewCo (known as Grünenthal Meds)

Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion is a parenteral therapy for rapid treatment of severe depletion or malabsorption of the water soluble vitamins B and C, including those related to alcohol misuse and malnutrition.1

Click here for prescribing information and adverse event reporting information.

LEARN MORE

Average:

  • References List label

    1. Vitamins B&C Kyowa Kirin Intravenous High Potency, Concentrate for Solution for Infusion Summary of Product Characteristics

    KKI/GB/PAB/0606 September 2024